2024 Q4 Form 10-Q Financial Statement
#000101738624000272 Filed on November 19, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
Revenue | ||
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $81.64K | |
YoY Change | 13.95% | |
Operating Profit | -$81.64K | |
YoY Change | 19.38% | |
Interest Expense | ||
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | -$2.061K | |
YoY Change | -642.37% | |
Pretax Income | ||
YoY Change | ||
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$83.70K | |
YoY Change | 23.07% | |
Net Earnings / Revenue | ||
Basic Earnings Per Share | $0.00 | |
Diluted Earnings Per Share | ||
COMMON SHARES | ||
Basic Shares Outstanding | 78.09M shares | 78.08M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | ||
YoY Change | ||
Cash & Equivalents | ||
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | $10.23K | |
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $11.35K | |
YoY Change | -53.0% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $2.749K | |
YoY Change | -26.34% | |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $2.749K | |
YoY Change | -26.34% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $11.35K | |
Total Long-Term Assets | $2.749K | |
Total Assets | $14.10K | |
YoY Change | -49.44% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $9.187K | |
YoY Change | -73.25% | |
Accrued Expenses | $14.81K | |
YoY Change | 36.26% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | ||
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $410.8K | |
YoY Change | 296.84% | |
LONG-TERM LIABILITIES | ||
Long-Term Debt | ||
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | ||
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $410.8K | |
Total Long-Term Liabilities | ||
Total Liabilities | $410.8K | |
YoY Change | 296.84% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$1.564M | |
YoY Change | 27.81% | |
Common Stock | $78.08K | |
YoY Change | -2.23% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$396.7K | |
YoY Change | ||
Total Liabilities & Shareholders Equity | $14.10K | |
YoY Change | -49.44% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$83.70K | |
YoY Change | 23.07% | |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | ||
YoY Change | ||
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | ||
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | ||
Cash From Investing Activities | ||
Cash From Financing Activities | ||
Net Change In Cash | ||
YoY Change | ||
FREE CASH FLOW | ||
Cash From Operating Activities | ||
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2355 Highway 36 West | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 400 | ||
dei |
City Area Code
CityAreaCode
|
(651) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
317-8990 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3486 | usd |
CY2023Q4 | scth |
Accounts Payable Related Party
AccountsPayableRelatedParty
|
40000 | usd |
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
3400 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
3 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
79863 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1076391 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1305128 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-148871 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
24217 | usd |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
4450 | usd |
us-gaap |
Revenues
Revenues
|
14235 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
10814 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
30839 | usd | |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
69906 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
265868 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
311183 | usd | |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
71646 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
265868 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
319684 | usd | |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-68390 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-255054 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-288845 | usd | |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
378 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3838 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1788 | usd | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-68012 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-258892 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-287057 | usd | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001703157 | ||
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
usd | |
CY2023Q4 | us-gaap |
Bank Overdrafts
BankOverdrafts
|
usd | |
CY2023Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
usd | |
CY2024Q3 | us-gaap |
Revenues
Revenues
|
usd | |
CY2024Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
usd | |
CY2024Q3 | us-gaap |
Gross Profit
GrossProfit
|
usd | |
CY2024Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
usd | ||
CY2024Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2024Q1 | scth |
Share Exchange Unrelated
ShareExchangeUnrelated
|
usd | |
CY2023Q2 | scth |
Share Exchange Unrelated
ShareExchangeUnrelated
|
usd | |
CY2023Q3 | scth |
Share Exchange Unrelated
ShareExchangeUnrelated
|
usd | |
scth |
Imputed Interest
ImputedInterest
|
usd | ||
us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
usd | ||
us-gaap |
Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
|
usd | ||
us-gaap |
Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
|
usd | ||
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
usd | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | ||
us-gaap |
Interest Paid
InterestPaid
|
usd | ||
scth |
Stock Issued2
StockIssued2
|
usd | ||
CY2024Q3 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
usd | |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
usd | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-55927 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
SecureTech Innovations, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
WY | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
82-0972782 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Roseville | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MN | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
55113 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
78086881 | shares |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5987 | usd |
CY2024Q3 | us-gaap |
Inventory Net
InventoryNet
|
10234 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
13656 | usd |
CY2024Q3 | us-gaap |
Deposit Assets
DepositAssets
|
1114 | usd |
CY2023Q4 | us-gaap |
Deposit Assets
DepositAssets
|
1088 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
11348 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
20731 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2749 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
14097 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
24217 | usd |
CY2024Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
9187 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5879 | usd |
CY2024Q3 | scth |
Accounts Payable Related Party
AccountsPayableRelatedParty
|
85978 | usd |
CY2024Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
269918 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
112328 | usd |
CY2024Q3 | us-gaap |
Bank Overdrafts
BankOverdrafts
|
182 | usd |
CY2024Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
14807 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
14564 | usd |
CY2024Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
29611 | usd |
CY2024Q3 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
1115 | usd |
CY2023Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
317 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
410797 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
173088 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
410797 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
173088 | usd |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
3400 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
3200 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
3200 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
3 | usd |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
78076881 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
78076881 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
79862655 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
79862655 | shares |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
78077 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1089240 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1564020 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-396700 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
14097 | usd |
us-gaap |
Revenues
Revenues
|
42050 | usd | |
CY2023Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1194 | usd |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
3421 | usd | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
11211 | usd | |
CY2023Q3 | us-gaap |
Gross Profit
GrossProfit
|
3256 | usd |
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
81642 | usd |
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1740 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8501 | usd | |
CY2024Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
81642 | usd |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-81642 | usd |
CY2024Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-2061 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-83703 | usd |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | ||
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
78076881 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
80615730 | shares |
us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
78170883 | shares | |
us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
98574867 | shares | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-148871 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-81481 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
230352 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
10000 | usd |
CY2024Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-93708 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
314060 | usd |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-83703 | usd |
CY2024Q3 | scth |
Imputed Interest
ImputedInterest
|
1063 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-396700 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
175420 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
20000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-113959 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
81461 | usd |
CY2023Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-105086 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
23625 | usd |
CY2023Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
16000 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-68012 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
75637 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-258892 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-287057 | usd | |
us-gaap |
Depreciation
Depreciation
|
737 | usd | |
us-gaap |
Depreciation
Depreciation
|
738 | usd | |
scth |
Imputed Interest
ImputedInterest
|
1063 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3422 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
12342 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
3308 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
32779 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
45978 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
242 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-2327 | usd | |
us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
157590 | usd | |
us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
45703 | usd | |
us-gaap |
Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
|
-26 | usd | |
us-gaap |
Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
|
29500 | usd | |
us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
798 | usd | |
us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
1770 | usd | |
us-gaap |
Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
|
182 | usd | |
us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-45598 | usd | |
us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-166552 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
10000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
36000 | usd | |
us-gaap |
Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
|
29611 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
39611 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
36000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-5987 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-130552 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5987 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
138318 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7766 | usd |
us-gaap |
Interest Paid
InterestPaid
|
3061 | usd | |
scth |
Stock Issued2
StockIssued2
|
5000 | usd | |
us-gaap |
Stock Issued1
StockIssued1
|
1796 | usd | |
us-gaap |
Stock Issued1
StockIssued1
|
27000 | usd | |
us-gaap |
Reclassifications
Reclassifications
|
<p id="xdx_84D_eus-gaap--Reclassifications_zUQaVggleaWe" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Reclassifications</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">For comparability, prior-year balances were reclassified to conform with current-year presentations, such as accounts payable—related party, which were previously included in accounts payable in 2023.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84A_eus-gaap--UseOfEstimates_zyy9Apa3y4gl" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates that have been made using careful judgment. Actual results may vary from these estimates.</p> <hr style="border-width: 0; margin: 14pt 0 0; height: 0; width: 0"/> <hr style="border-width: 0; margin: 8pt 0; page-break-after: always; height: 3pt; background-color: #909090"/> <p style="font: 10pt Times New Roman; margin: 0"> </p> <p style="font: 10pt Times New Roman; margin: 0"> </p> <hr style="border-width: 0; margin: 14pt 0 0; height: 0; width: 0"/> | ||
us-gaap |
Depreciation
Depreciation
|
737 | usd | |
us-gaap |
Depreciation
Depreciation
|
738 | usd | |
CY2024Q3 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
4916 | usd |
CY2023Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
4916 | usd |
CY2024Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2167 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1430 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2749 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3486 | usd |
us-gaap |
Fiscal Period
FiscalPeriod
|
<p id="xdx_846_eus-gaap--FiscalPeriod_zT9ERqd7uMX" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Fiscal Year</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The Company elected December 31st for its fiscal year end.</p> <p style="font: 10pt Times New Roman; margin: 0"> </p> | ||
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1564020 | usd |
CY2024Q3 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
1913 | usd |
CY2023Q4 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
1925 | usd |
CY2024Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
8321 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
11731 | usd |
CY2024Q3 | us-gaap |
Inventory Gross
InventoryGross
|
10234 | usd |
CY2023Q4 | us-gaap |
Inventory Gross
InventoryGross
|
13656 | usd |
CY2024Q3 | us-gaap |
Inventory Net
InventoryNet
|
10234 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
13656 | usd |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
|
250000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
3400 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
us-gaap |
Preferred Stock Conversion Basis
PreferredStockConversionBasis
|
200 | ||
us-gaap |
Common Stock Conversion Basis
CommonStockConversionBasis
|
1,795,774 | ||
CY2024Q3 | us-gaap |
Preferred Stock Conversion Basis
PreferredStockConversionBasis
|
700 | |
CY2024Q3 | us-gaap |
Common Stock Conversion Basis
CommonStockConversionBasis
|
7,000,000 | |
CY2024Q3 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
1.00 | |
CY2023Q3 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
1.75 | |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
78076881 | shares |
us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
80500000 | shares | |
us-gaap |
Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
|
13704226 | shares | |
us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
26795774 | shares | |
CY2023Q3 | scth |
Convertible Preferred Stock Shares Issued Upon Conversion Qtr
ConvertiblePreferredStockSharesIssuedUponConversionQtr
|
200 | shares |
CY2023Q3 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
2000000 | shares |
CY2023Q3 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
2700 | shares |
us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
27000000 | shares | |
CY2024Q3 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
200 | shares |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1795774 | shares | |
CY2024Q3 | scth |
Accrued Payroll
AccruedPayroll
|
260738 | usd |
CY2023Q4 | scth |
Accrued Payroll
AccruedPayroll
|
58500 | usd |
CY2023Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
4590 | usd |
CY2024 | us-gaap |
Payments For Royalties
PaymentsForRoyalties
|
1 | usd |
CY2023 | scth |
Patent Royalty Contribution
PatentRoyaltyContribution
|
2929 | usd |
CY2024Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
29611 | usd |
scth |
Imputed Interest
ImputedInterest
|
1063 | usd | |
CY2024Q3 | scth |
Accounts Payable Related Party
AccountsPayableRelatedParty
|
85978 | usd |
CY2023Q4 | scth |
Accounts Payable Related Party
AccountsPayableRelatedParty
|
40000 | usd |
CY2024Q4 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
10000 | usd |
CY2024Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
39611 | usd |
CY2024Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
0.50 | |
CY2024Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
78086881 | shares |
CY2024Q4 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
50000 | usd |
CY2024Q4 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
50000 | usd |
CY2024Q4 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
50000 | usd |
CY2024Q4 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
100000000 | shares |
CY2024Q4 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
10000 | shares |
CY2024Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
13400 | shares |